Characterization of an adhesion molecule that mediates leukocyte rolling on 24 h cytokine- or lipopolysaccharide-stimulated bovine endothelial cells under flow conditions.
Bovine gamma/delta T cells and neutrophils roll on 24 h cytokine- or lipopolysaccharide-stimulated bovine fetal umbilical cord endothelial cells in assays done under physiological flow. An antibody directed against E- and L-selectin has minimal blocking effect on this rolling interaction. mAbs were raised against the stimulated bovine endothelial cells and screened for inhibition of gamma/delta T cell rolling. One mAb (GR113) was identified that recognizes an antigen (GR antigen) selectively expressed by stimulated bovine endothelial cells isolated from fetal umbilical cord, mesenteric lymph nodes, and aorta. GR113 blocked bovine gamma/delta T cell as well as neutrophil rolling on the 24 h-activated endothelial cells. The GR antigen was constitutively expressed at low levels on the cell surface of platelets and its expression was not upregulated after stimulation of these cells with thrombin or phorbol myristate acetate. However, stimulated platelets released a soluble, functionally active form of the molecule that selectively bound in solution to gamma/delta T cells in a mixed lymphocyte preparation. GR113 mAb blocked the binding of the soluble platelet molecule to the gamma/delta T cells. Soluble GR antigen also bound a subset of human lymphocytes. Cutaneous lymphocyte-associated antigen (CLA) bright human lymphocytes exhibited the greatest capacity to bind the GR antigen, though CLA was not required for binding. Subsets of both human CD4 and CD8 T cells bound the GR antigen. Immunoprecipitation experiments showed the GR antigen to be 110-120 kD Mr. The binding of soluble GR antigen was inhibited by EDTA and O-sialoglycoprotease, but not neuraminidase treatment of the target cells.
Jutila
M A
MA
Veterinary Molecular Biology, Montana State University, Bozeman 59717, USA. uvsmj@gemini.oscs.montana.edu
Wilson
E
E
Kurk
S
S
D000818:Animals; D019138:Antibodies, Blocking / Q000494:pharmacology; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D000954:Antigens, Surface / Q000032:analysis / Q000378:metabolism / Q000502:physiology; D015153:Blotting, Western; D002417:Cattle; D015815:Cell Adhesion Molecules / Q000737:chemistry* / Q000502:physiology*; D002465:Cell Movement / Q000187:drug effects*; D016207:Cytokines / Q000276:immunology / Q000494:pharmacology*; D019040:E-Selectin / Q000032:analysis; D004591:Electrophoresis, Polyacrylamide Gel; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects* / Q000502:physiology*; D006801:Humans; D007962:Leukocytes / Q000502:physiology*; D008070:Lipopolysaccharides / Q000276:immunology / Q000494:pharmacology*; D016131:Lymphocyte Subsets / Q000276:immunology / Q000378:metabolism; D051379:Mice; D008807:Mice, Inbred BALB C; D009504:Neutrophils / Q000502:physiology; D019007:P-Selectin / Q000032:analysis; D015539:Platelet Activation / Q000276:immunology; D011233:Precipitin Tests; D011485:Protein Binding / Q000276:immunology; D016692:Receptors, Antigen, T-Cell, gamma-delta; D012212:Rheology; D012995:Solubility; D013194:Staining and Labeling; D016176:T-Lymphocyte Subsets / Q000502:physiology; D013997:Time Factors
D019138:Antibodies, Blocking; D000911:Antibodies, Monoclonal; D000954:Antigens, Surface; D015815:Cell Adhesion Molecules; D016207:Cytokines; D019040:E-Selectin; D008070:Lipopolysaccharides; D019007:P-Selectin; D016692:Receptors, Antigen, T-Cell, gamma-delta